文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

锰增强磁共振成像在Takotsubo综合征中的应用

Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome.
PubMed 文献 · Circulation · 2022-11-01

该研究纳入20例Takotsubo综合征患者和20名匹配志愿者,于急性期和恢复期(至少3个月后)行锰增强磁共振成像。结果显示患者急性期心肌锰摄取显著降低,恢复期左室射血分数和水肿恢复正常后锰摄取仍异常,提示心肌钙处理异常可能参与Takotsubo综合征的病理生理。

要点

  • Takotsubo综合征患者急性期心肌锰摄取较匹配志愿者显著降低。
  • 恢复期左室射血分数正常后,心肌锰摄取仍持续异常至少3个月。
  • 锰增强磁共振成像有望辅助Takotsubo综合征的诊断、表征和风险分层。

核心结论

  • Takotsubo综合征患者存在显著的心肌锰摄取异常,急性期最明显,且至少持续3个月,提示心肌钙处理异常可能参与其病理生理。

研究设计与样本

  • 研究纳入20例Takotsubo综合征患者(63±12岁,90%女性)和20名年龄、性别及心血管危险因素匹配的志愿者(59±11岁,70%女性),于2020年3月至2021年10月从Edinburgh心脏中心招募。
  • 患者在索引住院期间接受钆和锰增强磁共振成像,并在至少3个月后重复锰增强磁共振成像。

主要发现

  • 与匹配志愿者相比,患者左室射血分数降低(51±11 vs 67±8%;P<0.001),左室质量增加(86±11 vs 57±14 g/m2;P<0.001)。
  • 在受累心肌节段,患者初始原生T1(1358±49 vs 1211±28 ms;P<0.001)和T2(60±7 vs 38±3 ms;P<0.0001)值升高。
  • 锰增强成像动力学建模显示心肌锰摄取大幅降低(5.1±0.5 vs 8.2±1.1 mL/[100 g组织·min];P<0.0001)。
  • 恢复后,左室射血分数、左室质量和T2值与匹配志愿者相当,但原生及锰增强后T1和心肌锰摄取仍异常(6.6±0.5 vs 8.2±1.1 mL/[100 g组织·min];P<0.0001)。

临床怎么用

  • 锰增强磁共振成像有望用于Takotsubo综合征的诊断、表征和风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Takotsubo syndrome is an acute cardiac emergency characterized by transient left ventricular systolic dysfunction typically following a stressful event. Despite its rapidly rising incidence, its pathophysiology remains poorly understood. Takotsubo syndrome may pass unrecognized, especially if timely diagnostic imaging is not performed. Defective myocardial calcium homeostasis is a central cause of contractile dysfunction and has not been explored in takotsubo syndrome. We aimed to investigate myocardial calcium handling using manganese-enhanced magnetic resonance imaging during the acute and recovery phases of takotsubo syndrome. METHODS: Twenty patients with takotsubo syndrome (63±12 years of age; 90% female) and 20 volunteers matched on age, sex, and cardiovascular risk factors (59±11 years of age; 70% female) were recruited from the Edinburgh Heart Centre between March 2020 and October 2021. Patients underwent gadolinium and manganese-enhanced magnetic resonance imaging during index hospitalization with repeat manganese-enhanced magnetic resonance imaging performed after at least 3 months. RESULTS: Compared with matched control volunteers, patients had a reduced left ventricular ejection fraction (51±11 versus 67±8%; P<0.001), increased left ventricular mass (86±11 versus 57±14 g/m2; P<0.001), and, in affected myocardial segments, elevated native T1 (1358±49 versus 1211±28 ms; P<0.001) and T2 (60±7 versus 38±3 ms; P<0.0001) values at their index presentation. During manganese-enhanced imaging, kinetic modeling demonstrated a substantial reduction in myocardial manganese uptake (5.1±0.5 versus 8.2±1.1 mL/[100 g of tissue ·min], respectively; P<0.0001), consistent with markedly abnormal myocardial calcium handling. After recovery, left ejection fraction, left ventricular mass, and T2 values were comparable with those of matched control volunteers. Despite this, native and postmanganese T1 and myocardial manganese uptake remained abnormal compared with matched control volunteers (6.6±0.5 versus 8.2±1.1 mL/[100 g of tissue ·min]; P<0.0001). CONCLUSIONS: In patients with takotsubo syndrome, there is a profound perturbation of myocardial manganese uptake, which is most marked in the acute phase but persists for at least 3 months despite apparent restoration of normal left ventricular ejection fraction and resolution of myocardial edema, suggesting abnormal myocardial calcium handling may be implicated in the pathophysiology of takotsubo syndrome. Manganese-enhanced magnetic resonance imaging has major potential to assist in the diagnosis, characterization, and risk stratification of patients with takotsubo syndrome. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT04623788.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Singh T, Joshi S, Kershaw LE, et al. Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome. Circulation. 2022. PMID: 36317524. doi:10.1161/CIRCULATIONAHA.122.060375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。